Cilinski Lynn

Avg. Two Year Performance

No purchase track record

50% Avg. Sale Return

22% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	1%	21%	22%	28%	50%
Sale Success Rate	3 of 6	4 of 6	5 of 6	6 of 6	6 of 6

MacRogenics Inc

Drugs » Biotechnology

VP, Controller and Treasurer:

Holdings: 6.21K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--